Related Experiment Video
Updated: Oct 10, 2026

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c
B Wagenknecht1, M Hermisson, P Groscurth
1Laboratory of Molecular Neuro-Oncology, Department of Neurology, University of Tübingen, School of Medicine, Tübingen, Germany.
Abstract:
The proteasome is a multiprotein complex that is involved in the intracellular protein degradation in eukaryotes. Here, we show that human malignant glioma cells are susceptible to apoptotic cell death induced by the proteasome inhibitors, MG132 and lactacystin. The execution of the apoptotic death program involves the processing of caspases 2, 3, 7, 8, and 9. Apoptosis is inhibited by ectopic expression of X-linked inhibitor of apoptosis (XIAP) and by coexposure to the broad-spectrum caspase inhibitor, benzoyl-VAD-fluoromethyl ketone (zVAD-fmk), but not by the preferential caspase 8 inhibitor, crm-A. It is interesting that specific morphological alterations induced by proteasome inhibition, such as dilated rough endoplasmic reticulum and the formation of cytoplasmic vacuoles and dense mitochondrial deposits, are unaffected by zVAD-fmk. Apoptosis is also inhibited by ectopic expression of Bcl-2 or by an inhibitor of protein synthesis, cycloheximide. Further, cytochrome c release and disruption of mitochondrial membrane potential are prominent features of apoptosis triggered by proteasome inhibition. Bcl-2 is a stronger inhibitor of cytochrome c release than zVAD-fmk. XIAP and crm-A fail to modulate cytochrome c release. These data place cytochrome c release downstream of Bcl-2 activity but upstream of XIAP- and crm-A-sensitive caspases. The partial inhibition of cytochrome c release by zVAD-fmk indicates a positive feedback loop that may involve cytochrome c release and zVAD-fmk-sensitive caspases. Finally, death ligand/receptor interactions, including the CD95/CD95 ligand system, do not mediate apoptosis induced by proteasome inhibition in human malignant glioma cells.
Insights
Proteasome inhibitors induce apoptosis in malignant glioma cells via caspase activation and mitochondrial pathways. This cell death is regulated by Bcl-2, XIAP, and caspase activity, but not death ligand signaling.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The proteasome is crucial for intracellular protein degradation in eukaryotes.
- Malignant gliomas are aggressive brain tumors with limited treatment options.
Purpose of the Study:
- To investigate the mechanisms of apoptosis induced by proteasome inhibitors in human malignant glioma cells.
- To elucidate the role of caspases, Bcl-2, XIAP, and mitochondrial pathways in this process.
Main Methods:
- Treatment of human malignant glioma cells with proteasome inhibitors (MG132, lactacystin).
- Assessment of apoptosis using caspase activation, morphological changes, and mitochondrial membrane potential.
- Inhibition studies using ectopic expression of XIAP and Bcl-2, and caspase inhibitors (zVAD-fmk, crm-A).
Main Results:
- Proteasome inhibitors trigger apoptosis involving caspases 2, 3, 7, 8, and 9.
- Apoptosis is inhibited by XIAP, Bcl-2, and cycloheximide, but not by crm-A.
- Cytochrome c release and mitochondrial membrane potential disruption are key events, with Bcl-2 being a potent inhibitor.
- Specific morphological alterations are independent of broad-spectrum caspase inhibition.
Conclusions:
- Proteasome inhibition induces apoptosis in malignant glioma cells through caspase-dependent and mitochondrial pathways.
- Bcl-2 and XIAP play significant roles in regulating this apoptotic process.
- Cytochrome c release occurs upstream of XIAP- and crm-A-sensitive caspases, suggesting a complex regulatory network.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
